Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Predictions

buy
Pro-Dex Inc.

Start price
Target price
Perf. (%)
€14.00
26.02.23
-
26.02.24
7.86%
27.02.24

buy
Sientra Inc.

Start price
Target price
Perf. (%)
€1.84
02.02.23
€3.60
02.02.24
-4.62%
06.02.23

Could be very worthwhile Investment >20% year
buy
InVivo Therapeutics Holdings

Start price
Target price
Perf. (%)
€2.16
10.01.23
€4.00
31.12.25
-46.57%
05.05.23

Could be very worthwhile Investment >20% year
Vyant Bio Inc.

Start price
Target price
Perf. (%)
€1.55
05.01.23
-
05.01.24
-65.81%
02.04.23

buy
HTG Molecular Diagnostics Inc.

Start price
Target price
Perf. (%)
€3.79
27.12.22
-
27.12.23
-90.75%
29.07.23

Capable Management
Risky Investment
No uniques
No Innovation
buy
Hologic Inc.

Start price
Target price
Perf. (%)
€69.65
22.12.22
-
22.12.23
-0.67%
24.08.23

HTG Molecular Diagnostics Inc.

Start price
Target price
Perf. (%)
€19.20
12.12.22
€0.000
12.12.23
-63.50%
15.12.22

Capable Management
Risky Investment
No uniques
No Innovation
buy
Cardiff Oncology Inc.

Start price
Target price
Perf. (%)
€1.24
17.11.22
-
17.11.23
0.48%
26.12.22

Risky Investment
buy
Davita Inc.

Start price
Target price
Perf. (%)
€73.02
28.10.22
-
0.45%
28.10.22

Risky Investment
buy
Motus GI Holdings Inc.

Start price
Target price
Perf. (%)
€2.12
24.10.22
€3.00
24.10.23
-73.07%
25.10.23

Could be worthwhile Investment >10% per year
Motus GI Holdings Inc.

Start price
Target price
Perf. (%)
€1.97
10.10.22
€0.000
10.10.23
-6.09%
16.10.22

Probably not worthwhile Investment
Revenue decline/stagnation expected
EBIT decline/stagnation expected
Decining EBIT margin than peer group
buy
Illumina Inc.

Start price
Target price
Perf. (%)
€219.65
06.10.22
-
06.10.23
-39.65%
06.10.23

buy
Motus GI Holdings Inc.

Start price
Target price
Perf. (%)
€2.26
03.10.22
€3.00
03.10.23
22.12%
06.10.22

Could be worthwhile Investment >10% per year
Capable Management
Very good company culture
Little innovation
buy
scPharmaceuticals

Start price
Target price
Perf. (%)
€6.15
29.09.22
€8.00
31.12.24
-23.25%
10.10.22

Could be very worthwhile Investment >20% year
Vivani Medical Inc.

Start price
Target price
Perf. (%)
€2.81
19.09.22
-
19.09.23
-67.84%
24.04.23

Probably not worthwhile Investment
buy
Cardiff Oncology Inc.

Start price
Target price
Perf. (%)
€1.65
18.09.22
-
18.09.23
-3.77%
01.10.22

Risky Investment
buy
Cardiff Oncology Inc.

Start price
Target price
Perf. (%)
€1.62
14.09.22
-
14.09.23
1.70%
17.09.22

Risky Investment
buy
Cardiff Oncology Inc.

Start price
Target price
Perf. (%)
€2.62
13.09.22
-
13.09.23
-37.10%
17.09.22

Could be very worthwhile Investment >20% year
buy
Thermo Fisher Scientific Inc.

Start price
Target price
Perf. (%)
€551.50
07.09.22
€700.00
31.12.25
-10.44%
05.05.23

Could be very worthwhile Investment >20% year
buy
Ocular Therapeutix Inc.

Start price
Target price
Perf. (%)
€5.70
07.09.22
€10.00
31.12.24
25.06%
02.08.24

Could be very worthwhile Investment >20% year
buy
ShockWave Medical Inc

Start price
Target price
Perf. (%)
€285.40
07.09.22
€400.00
31.12.25
-47.00%
12.11.23

Could be very worthwhile Investment >20% year
buy
Glaukos Corp

Start price
Target price
Perf. (%)
€58.00
07.09.22
€63.00
07.09.23
-8.62%
08.05.23

Could be worthwhile Investment >10% per year
Nuwellis Inc.

Start price
Target price
Perf. (%)
€1.69
31.08.22
-
31.08.23
-93.25%
18.05.23

Could be very worthwhile Investment >20% year
Nuwellis Inc.

Start price
Target price
Perf. (%)
€1.26
31.08.22
-
31.08.23
-90.95%
29.05.23

Could be very worthwhile Investment >20% year
buy
ShockWave Medical Inc

Start price
Target price
Perf. (%)
€288.60
16.08.22
-
16.08.23
-29.14%
16.08.23